Navigation Links
Beaumont Doctor's Invention Improves Cataract Surgery Outcomes
Date:8/26/2008

ROYAL OAK, Mich., Aug. 26 /PRNewswire/ -- The Beaumont Commercialization Center, a medical technology development company within Beaumont Hospitals, is making an innovative ophthalmic lens support system available for licensing.

Timothy Page, M.D., a Beaumont ophthalmologist, developed the advanced lens support system to stabilize the lens before or during cataract surgery, thereby preventing the movement of lens fragments into the back of the eye.

Each year, approximately 10 million people worldwide have cataract surgery. Elements of the eye, such as vitreous body or the lens capsule, can shift as the cataract is removed. Vitreous body, a clear gel that fills the eyeball behind the lens, can move into the front of the eye when the lens is not fully supported. This movement can lead to complications such as capsule tears, zonular dialysis, and dislocation of the lens into the back of the eye, requiring the patient to have an additional surgery by a retina specialist.

"I am excited to be able to bring something like this to market," said Dr. Page, who has been in practice for 14 years. "The system is an important development in minimizing risks and complications that can occur in such a common procedure." Dr. Page has offices in Troy and Birmingham, Michigan.

Other techniques with various apparatus do exist, such as the use of a net or levitation using the tip of a probe. They are not ideal for various reasons. A net can block the needed removal of lens fragments while the extremely small diameter of a probe makes it a challenge for even experienced surgeons to balance and elevate lens fragments.

This new lens support system consists of a cannula and a piston. By means of the piston, the lens support is movable to contracted and expanded configurations.

For licensing information, contact Mike Tanner, Director of Technology Development, at (248) 551-0567 or email him at michael.tanner@beaumonthospitals.com .

For additional information on this and other licensing opportunities from the Beaumont Commercialization Center, please visit http://www.BeaumontCommercializationCenter.com .

About the Beaumont Commercialization Center

Part of Beaumont Hospitals, headquartered in Royal Oak, MI, the Beaumont Commercialization Center is a hospital-based medical device development resource focused on helping manufacturers and inventors bring their ideas for new medical devices and technology to reality. The full-service center blends product development knowledge with the experience of physicians and clinical staff at Beaumont Hospitals.

The Beaumont Commercialization Center offers intellectual property, design engineering, prototype services, usability testing, clinical trials, and regulatory assistance. For more information about the Beaumont Commercialization Center, visit http://www.beaumontcommercializationcenter.com .


'/>"/>
SOURCE Beaumont Commercialization Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beaumont Technology Usability Center To Offer Training For Medical Technology Companies
2. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
3. Beaumont Hospitals in Michigan Selects Halogen Software for Pay for Performance System
4. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
5. Black Enterprise Unveils Americas Leading Doctors
6. Special coating greatly improves solar cell performance
7. Method to deliver molecules within embryonic stem cells improves differentiation
8. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
9. Elusys Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection
10. Survey: 90% of Participating Surgeons Report Syndicom SpineConnect Improves Practice of Spine Surgery
11. Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... Franz Inc. , an ... technology has been recognized As “ Best in Semantic Web Technology - USA ... Corporate America, it’s our priority to showcase prominent professionals who are excelling in ...
(Date:2/3/2016)... , Feb. 3, 2016  With the ... patent cliff that is underway, therapies such as ... for a whole host of indications are in ... aid in the development and production of these ... poor quality and high costs, novel approaches and ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences is currently in ... to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company ... , Following on from the first misfolded Amyloid beta target announced on Nov. ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... to aid in the rapid development and ongoing quality control of molecular assays ... outbreak is extremely high,” Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix, ...
Breaking Biology Technology:
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , Jan. 8, ... of innovative sensor-based diagnostic products, today announced the closing of ... and existing investors.  Proceeds from the financing will be used ... a hand-held device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction ...
Breaking Biology News(10 mins):